Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Vanquish® Water Vapor Ablation for Grade Group 3 PrOstate CanceR: A Multicenter Single Arm Study

NCT07652164 is registered in ClinicalTrials.gov with Francis Medical Inc. as lead sponsor.

NCT NCT07652164
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07652164 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Vanquish® Water Vapor Ablation for Grade Group 3 PrOstate CanceR: A Multicenter Single Arm Study
Lead sponsor
Francis Medical Inc.
Phase
Not applicable
Overall status
Not yet recruiting
Start date
August 31, 2026
Completion date
September 30, 2028
Enrollment
120 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer